Renal Cell Carcinoma (RCC)

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Multimodal Machine Learning Characterization of Solid Tumors

Validation of RCC Predicting Model With Emulated-target Trial

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

CBCT Guided Markerless SBRT for Renal Cell Cancer

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis

Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)

Investigation of Lymph Node Biology in Kidney Cancer

Cabozantinib Dose Skipping as an Alternative to Dose Reductions

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors